- Data released by Iovance Biotherapeutics, Inc. shows that its core therapy Lifileucel demonstrates a favorable safety profile.
- Avanos Medical Inc announces the expansion of its transformation plan, expecting these initiatives to deliver incremental annualized savings of $15 million to $20 million by the end of 2026.
- Biopharmaceutical company Fulcrum Therapeutics recently disclosed that by the end of 2025, its total holdings of cash, cash equivalents, and marketable securities will reach $352.3 million.
- First Watch Restaurant Group recently announced its capital expenditure plan for fiscal year 2026, with a total investment expected to reach $150 millions to $160 millions.
- Iovance Biotherapeutics recently announced plans to launch a single-arm registration clinical trial in the second quarter of 2026.
- According to the latest guidance median forecast, the 2026 adjusted EBITDA of Enviri Corporation's two core businesses—Harsco Environmental and Harsco Rail—is expected to see a slight decline compared to 2025.
- Iovance Biotherapeutics recently announced that its tumor-infiltrating lymphocyte (TIL) therapy for soft tissue sarcoma has achieved positive results in its first clinical trial.
- Enviri Corporation recently released a forecast stating that the cumulative net impact of the company’s pension obligations is expected to reach approximately $18 million by the end of 2025.
- Keurig Dr Pepper (NASDAQ:KDP) Exceeds Q4 CY2025 Expectations
- Solana Signals Clash as $68 Support Holds While RWA Hits $1.68B
- Insmed Incorporated (INSM) Gained from Its Lead Product ARIKAYCE
- Galaxy Digital Spotlights Stablecoins and Smart Contracts Reshaping Blockchain Lending
- Saxo Bank: Cryptocurrencies fall as risk-off sentiment rises
- Gilat Receives $39 Million in Orders for Sidewinder ESA Terminals
- Oil: Escalation risks and fair value gap – Commerzbank
- US Stocks Move｜AMD Surges Over 13% Pre-market After Reaching Multi-Billion Dollar AI Equipment Procurement Deal with Meta
- AI agents can’t run wild without on-chain identity | Opinion
- Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
- XRP Price Tests Crucial Floor, Bearish Bias Strengthens Further
- Crypto markets bleed as bitcoin hovers above liquidation zone
- Pundit: February 29 Will Be Huge for XRP. Just Got Some Massive Inside Info
- Pundit: February 29 Will Be Huge for XRP. Just Got Some Massive Inside Info
- Ocular Therapeutix to Participate in March Investor Conferences
- Ocular Therapeutix to Participate in March Investor Conferences
- Iovance Announces Positive Results from the First Clinical Trial for TIL Cell Therapy in Soft Tissue Sarcomas
- Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
- Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street
- Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
- Shoals Technologies Group, Inc. Reports Financial Results for Fourth Quarter 2025
- Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET
- Axsome Therapeutics Initiates CLARITY Phase 3 Trial of Solriamfetol in Adults with Major Depressive Disorder with Excessive Daytime Sleepiness Symptoms
- Avalo Therapeutics to Participate in Upcoming Investor Conferences
- Dianthus Therapeutics to Participate in The TD Cowen 46th Annual Health Care Conference
- Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
- Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook
- Atea Pharmaceuticals Presents Preclinical Results Supporting First-in-Class Potential of AT-587 for Treatment of Hepatitis E Virus at CROI 2026
- EyePoint Announces Participation at Upcoming Investor Conferences
- Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
- iBio to Participate in Upcoming Investor Conferences
- Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026
- Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
- Uber's Bet On SpotHero Could Set New Standard For Urban Mobility
- Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
- Mobilicom to Participate at Enforce Tac 2026, Germany's Prominent Trade Fair for Security and Defense
- Shoals Technologies Group and ON.energy to Deploy Critical-Power Systems for Leading AI Data-Center Operator
- Option Care Health Announces Financial Results for Fourth Quarter and Full Year 2025
- Autolus Therapeutics to Participate in Upcoming Investor Conferences
- Cipher Digital Provides Fourth Quarter and Full Year 2025 Business Update
- Kymera Therapeutics to Participate in Upcoming March Investor Conferences
- DOGE chart targets $0.06 with weak volume, MAs still bearish
- I Would Raise CrowdStrike (CRWD)'s Numbers, Says Jim Cramer
- Chevron (CVX)'s the Only Company I Would Buy Here, Says Jim Cramer
- QuantumScape (QS)'s Been a Tough Own, Says Jim Cramer
- Microsoft (MSFT) Needs a Refresh, Says Jim Cramer
- Elanco (NYSE:ELAN) Surprises With Q4 CY2025 Sales
- "I'm on the Wrong Side of History With Salesforce (CRM)," Says Jim Cramer
- Maybe We Hate Intel (INTC) Too Much, Says Jim Cramer
- I'm Not a Buyer of Workday (WDAY), Says Jim Cramer
- Is GOOGL Stock's Bull Run Over? Charles Moon Is Betting Against Alphabet This March, Expects 4% Decline
- I Trust GE Vernova (GEV) CEO, Says Jim Cramer
- Jim Cramer Discusses Cadence Design Systems (CDNS)
- Jim Cramer Discusses Palo Alto Networks' (PANW) Earnings
- Elon Musk really took the steering wheel off.
- IoTeX L1 resumes operation and completes upgrade
- El Salvador advances Bitcoin education reform in the public education system
- Hyperscale Data's bitcoin holdings increase to approximately 605 BTC, with a portfolio value reaching $41 million.
- Target Hospitality Corp. has officially launched a new construction project.
- American Homes 4 Rent (AMH) Reports 2025 Core FFO Growth of 5.4% and $439M Net Income
- ANI Pharmaceuticals to Present at Upcoming Investor Conferences
- Ambiq Micro (AMBQ) Launches soundKIT AI Development Kit for Ultra-Low-Power Edge Devices
- Fed's Bostic: Central bank must maintain attention on inflation – Reuters
- Xenia Hotels & Resorts recently disclosed that operational disruptions caused by renovation projects at its hotels are expected to negatively impact the company’s financial performance in 2026.
- Ceco Environmental announces a strategic merger agreement with Thermon Group; both parties will integrate resources to jointly build a leading global provider of critical environmental and thermal solutions for the industrial sector.
- Medical device service provider InfuSystems Holdings Inc announced that, due to a structural adjustment of its biomedical service contract portfolio, its annual operating revenue is expected to decrease to $7.1 million starting from fiscal year 2026.
- According to data as of February 19, Xenia Hotels & Resorts Inc (stock code: XHR) expects its same-store revenue per available room (RevPAR) in the first quarter of this year to increase by approximately 4.6% compared to the same period in 2025.
- National Bank of the United Arab Emirates has opened up the possibility of allocating bitcoin in its investment process.
- BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026
- Global Indemnity Group 2025 Earnings Release & Conference Call
- US dollar projected to fall in 2026: driven more by cyclical trends than by fundamental shifts
- US Stocks Movement | Most of the Tech Magnificent Seven Rebound in Pre-market Trading
- Dogecoin Crypto Price: bears in control as volatility compression sets up the next move
- Shiba Inu Forecast for Feb 24: Can SHIB Reclaim $0.0000070 Amid Massive Futures Outflows?
- Bitcoin Cash extends losses, dumps 10% amid BTC sell-off
- Jim Chanos Says Elon Musk's Orbital Datacenter Goal Is 'Absurd', Slams Argument That Power Is The Issue: 'Not A Long-Term Bottleneck'
- Shiba Inu Death Cross Adds Fresh Pressure on Key Support
- Bitcoin Dips Under $63,000 and History Says More Pain Ahead Before Bottom Forms
- New Weight Loss Drugs from Novo Nordisk and Federal Biotechnology Help Patients Lose Weight
- Analysis: Schroders' Acquisition Deal May Trigger Sale of Non-core Assets
- Options Income Daily: CRWV, ORCL, RKLB and More
- Top Gap Ups and Downs on Friday: WMT, ORCL, NVO and More
- Options Income Daily: CRWV, ORCL, RKLB and More
- Today's Analyst Rating | Wells Fargo Upgrades Alphabet-A to Buy, Wells Fargo Upgrades Alphabet-C to Buy
- Daily short sale tracking: NVIDIA's short volume increased by 13 million, with a short sale ratio of 14%
- Asia Shares Hesitant, Dollar Slips Amid Tariff Confusion
- Options Market Statistics | Alphabet-A Up 4.01%, Put Call Ratio Drop To 0.63
- Today's Bullish Patterns & Technical Sentiment | Published on 02/23: CDP, FRPT, YUM and More
- Unusual Options Activity: EQT, JPM and Others Attract Market Bets, EQT V/OI Ratio Reaches 787.7
- Earnings Preview: CoreWeave to Report Financial Results Post-market on February 26
- BRIEF-Musk's XAI And Pentagon Reach Deal To Use Grok In Classified Systems - Axios
- While Gold And Copper Grab Headlines, This Forgotten Metal Is Up 500%
